Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Special Issue 9 (2022)

The safety of nutraceuticals monitoring through pharmacovigilance programme of India

Author(s):
Pallavi Kumari, Jyotirmayee Sahoo and Ayusi Satapathy
Abstract:
The term "Nutraceutical" was coined by combining the terms "Nutrition" and "Pharmaceutical" in 1989 by Dr. Stephen De Felice, Chairman of the Foundation for Innovation in Medicine. “Nutraceutical” is a marketing term developed for nutritional supplement that is sold with the intent to treat or prevent diseases. Nutraceutical refers to a food having medicinal effect on human health. It consists of food supplements, herbal products, probiotics and prebiotics meant for prevention and treatment of diseases. The Pharmacovigilance Program of India (PvPI) was launched with a broad objective to safeguard the health of 1.27 billion people of India since the adverse drug Reactions (ADRs) are reported from all over the country to NCC-PvPI. The Pharmacovigilance Program of India (PvPI) also works in collaboration with the WHO Programme for International Drug Monitoring (PIDM) and contributes to the Global ADRs database. In 2017, the Pharmacovigilance Programme of India (PvPI) and Indian Pharmacopoeia Commission (IPC), Ghaziabad, India together became as a WHO Collaborating Centre. The Pharmacovigilance Programme of India encourages all healthcare professionals and consumers to report ADRs associated with nutraceuticals. The submitted ADR reports are reviewed and analyzed at NCC and finally submitted to World Health Organization - Uppsala Monitoring Centre (WHO-UMC), Sweden.
Pages: 2498-2505  |  554 Views  383 Downloads
How to cite this article:
Pallavi Kumari, Jyotirmayee Sahoo and Ayusi Satapathy. The safety of nutraceuticals monitoring through pharmacovigilance programme of India. The Pharma Innovation Journal. 2022; 11(9S): 2498-2505.

Call for book chapter